Kenya positioned for early preparation of investigational monthly HIV prevention option
NAIROBI, 24 July 2026 – Kenya will play a dual role in the development and potential future supply of alimatravir, an investigational once-monthly oral pre-exposure prophylaxis option being studied for the prevention of HIV-1. MSD, known as Merck in the…